Skip to main content
SpringerLink
Log in

Subcutaneously administered somatostatin analogue in traumatic pancreatic fistula

  • Letter to the Editor
  • Published:
Pediatric Surgery International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kwan D, Aufses AH (1989) Short term administration of SMS 201-995 in the management of external pancreatic fistula. Am J Gastrol 84: 326–328

    Google Scholar 

  2. Ohta T, Nagakawa T, Mori K, Kanno M, Kayahara M, et al. (1992) Effects of SMS 201-995 on exocrine pancreatic secretion in a patient with external pancreatic fistula. Int J Pancreat 11: 185–189

    Google Scholar 

  3. Tulassay Z, Flautner L, Vadasz A, Fehervari I (1993) Short report: octreotide in the treatment of external pancreatic fistulas. Alimentary Pharm Therap 7: 323–325

    Google Scholar 

  4. VanderKolk W, Scholten D, Schlatter M, Connors R (1995) Traumatic pancreatic fistula in children: early management with a somatostatin analogue and drainage. Pediatr Surg Int 11: 22–25

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Paediatric Surgery, Royal Aberdeen Children's Hospital, Cornhill Road, AB9 2ZG, Aberdeen, Scotland

    A. Mahomed

Authors
  1. A. Mahomed
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mahomed, A. Subcutaneously administered somatostatin analogue in traumatic pancreatic fistula. Pediatr Surg Int 12, 231 (1997). https://doi.org/10.1007/BF01350017

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01350017

Keywords

Search

Navigation